Scientists Accuse Government of Dishonesty Over GM Babies in its Regulation of new IVF Technique
By Steve Connor,
The Independent
| 07. 28. 2014
Untitled Document
The Government has been accused of misleading the public over the introduction of a new in vitro fertilisation (IVF) technique that some experts believe will result in the birth of “genetically modified babies”.
Leading scientists, including Lord Winston, an early pioneer of fertility treatment, have criticised the Department of Health for trying to play down a process that will for the first time allow the alteration of the DNA of future generations.
They argue that the Government has redefined the term “genetic modification” (GM) to exclude specifically a controversial technique that will result in babies inheriting genetic material from three individuals.
The move, buried within a Department of Health document published last week, is designed to take the sting out of hostility towards mitochondrial donation – a process that aims to avoid the certain inherited diseases being passed on by using healthy mitochondria (microscopic structures in the cell) taken from a donor egg or embryo. Opponents believe that using the healthy donor mitochondria will result in “three-parent embryos” and could usher in an era of “designer babies”...
Related Articles
By Samuelle Fajutrao Falk , The Conversation | 06.26.2026
When my colleagues and I asked autistic people and parents of autistic children in Sweden how they feel about genetic research in autism, one response stood out: “I hope genetic research finds new ways to help us, not erase us.”...
By Rebecca Simkin, BioNews | 06.29.2026
The US Food and Drug Administration (FDA) is allowing biotech company Regenxbio to reapply for licensing of a gene therapy for Hunter syndrome, in a reversal of its previous decision. Hunter syndrome, or mucopolysaccharidosis type II (MPS II), is a...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Paul Knoepfler, Stat | 06.24.2026
What if you could precisely change the genome of a pre-implantation human embryo and then safely use that embryo to try to generate a healthier person? It’s a wild idea, but one that technology over the past decade has steadily...
